{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T13:57:16Z","timestamp":1706104636785},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,10,2]],"date-time":"2002-10-02T00:00:00Z","timestamp":1033516800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> In the peripheral blood (PB) of multiple myeloma (MM) patients, clonotypic B cells are present that express the identical V(D)J rearrangements as the malignant plasma cells in the bone marrow. In the present study, the proliferative capacity of clonotypic B cells from MM patients (<jats:italic>n<\/jats:italic>\u2003=\u200310) and the ability to differentiate <jats:italic>in vitro<\/jats:italic> was determined using the CD40\u2010culturing system. For six patients, the presence of clonotypic B cells expressing variant immunoglobulin (Ig) isotypes was assessed by Ig isotype\u2010specific allele\u2010specific oligonucleotide reverse transcription polymerase chain reaction (ASO\u2010RT\u2010PCR) after culturing with CD40L and interleukin 4 (IL\u20104). In three out of six patients, clonotypic B cells expressing variant isotypes were detected both before and after culturing. The ability of clonotypic B cells to undergo B\u2010cell differentiation was studied by abrogating CD40 signalling accompanied by IL\u201010 and IL\u20102 stimulation, enhancing differentiation towards Ig\u2010secreting cells. The numbers of clonotypic B cells were determined by quantitative ASO\u2010PCR. An increase in cell number was observed upon CD40L and IL\u20104 stimulation, whereas the relative number of clonotypic B cells was unaltered. In contrast, upon B\u2010cell differentiation the relative number of clonotypic B cells decreased. In conclusion, clonotypic B cells can be cultured and isolated <jats:italic>in vitro<\/jats:italic> using the CD40 system. Clonotypic B cells responded to CD40 triggering in a similar fashion as to non\u2010clonotypic normal B cells. However, the ability of clonotypic B cells to undergo <jats:italic>in vitro<\/jats:italic> activation and differentiation into Ig\u2010secreting cells is hampered.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03789.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:47:57Z","timestamp":1047365277000},"page":"54-61","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myeloma clonotypic B cells are hampered in their ability to undergo B\u2010cell differentiation <i>in vitro<\/i>"],"prefix":"10.1111","volume":"119","author":[{"given":"Jeroen E. J.","family":"Guikema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edo","family":"Vellenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen H. C.","family":"Bakkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaas A.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,10,2]]},"reference":[{"key":"e_1_2_18_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.173"},{"key":"e_1_2_18_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.6.2219"},{"key":"e_1_2_18_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"e_1_2_18_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.9.2326.2326"},{"key":"e_1_2_18_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04872.x"},{"key":"e_1_2_18_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059611"},{"key":"e_1_2_18_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.065005348.x"},{"key":"e_1_2_18_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00842.x"},{"key":"e_1_2_18_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.2.436.436"},{"key":"e_1_2_18_11_1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood.V80.7.1818.1818","article-title":"Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients","volume":"80","author":"Billadeau D.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_18_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1023"},{"key":"e_1_2_18_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.1.289.289"},{"key":"e_1_2_18_14_1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V87.5.1972.1972","article-title":"Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells","volume":"87","author":"Chen B.J.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_18_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I"},{"key":"e_1_2_18_16_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1091"},{"key":"e_1_2_18_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U"},{"key":"e_1_2_18_18_1","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood.V88.10.3972.bloodjournal88103972","article-title":"Interleukin\u201010 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop","volume":"88","author":"Gu Z.J.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_18_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01233.x"},{"key":"e_1_2_18_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3077.bloodjournal85113077"},{"key":"e_1_2_18_21_1","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.154.9.4341","article-title":"The role of IL\u201010 in human B cell activation, proliferation, and differentiation","volume":"154","author":"Itoh K.","year":"1995","journal-title":"Journal of Immunology"},{"key":"e_1_2_18_22_1","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1182\/blood.V85.9.2521.bloodjournal8592521","article-title":"Interleukin\u201010 is a proliferation factor but not a differentiation factor for human myeloma cells","volume":"85","author":"Lu Z.Y.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_18_23_1","first-page":"4058","article-title":"Detection of t(4;14) (p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription\u2010polymerase chain reaction analysis of IGH\u2010MMSET fusion transcripts","volume":"60","author":"Malgeri U.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_18_24_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.8.4097"},{"key":"e_1_2_18_25_1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V83.3.724.724","article-title":"Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug\u2010resistant disease in multiple myeloma","volume":"83","author":"Pilarski L.M.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_18_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054775"},{"key":"e_1_2_18_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.9.3751"},{"key":"e_1_2_18_28_1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V95.3.1056.003k26_1056_1065","article-title":"Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self\u2010renewal of primary human myeloma in the bone marrow of NOD SCID mice","volume":"95","author":"Pilarski L.M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_18_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80578-6"},{"key":"e_1_2_18_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.1.219"},{"key":"e_1_2_18_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7101(88)90020-7"},{"key":"e_1_2_18_32_1","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood.V89.5.1824","article-title":"CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient\u2010specific IgH VDJ gene rearrangements","volume":"89","author":"Szczepek A.J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_18_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2844"},{"key":"e_1_2_18_34_1","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis","volume":"126","author":"Taswell C.","year":"1981","journal-title":"Journal of Immunology"},{"key":"e_1_2_18_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(92)90223-7"},{"key":"e_1_2_18_36_1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.4049\/jimmunol.155.5.2487","article-title":"Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity","volume":"155","author":"Vescio R.","year":"1995","journal-title":"Journal of Immunology"},{"key":"e_1_2_18_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401829"},{"key":"e_1_2_18_38_1","first-page":"63","article-title":"Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium\u2013Dutch Hematology\u2013Oncology Group","volume":"96","author":"Willems P.","year":"2000","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03789.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03789.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03789.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:13:59Z","timestamp":1697379239000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03789.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03789.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03789.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"2002-10-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}